EcoDrugPlus

Il2 Inducible T Cell Kinase

Ensembl ID : ENSDARG00000017565
Gene Symbol: ITK
7 Enzyme and pathways 5 Cross references
208 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSDARG00000042336
Gene Symbol: IMPDH1A
7 Enzyme and pathways 5 Cross references
259 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1b

Ensembl ID : ENSDARG00000029524
Gene Symbol: IMPDH1B
7 Enzyme and pathways 5 Cross references
258 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSDARG00000006900
Gene Symbol: IMPDH2
7 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSDARG00000020625
Gene Symbol: JAK1
27 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSDARG00000104808
Gene Symbol: JAK2A
13 Enzyme and pathways 5 Cross references
198 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSDARG00000018882
Gene Symbol: JAK2B
42 Enzyme and pathways 5 Cross references
194 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase B

Ensembl ID : ENSDARG00000056133
Gene Symbol: KITB
5 Cross references
208 Possible Orthologues:

Kell Metallo-Endopeptidase (Kell Blood Group)

Ensembl ID : ENSDARG00000076950
Gene Symbol: KEL
5 Cross references
229 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSDARG00000067916
Gene Symbol: LYN
5 Cross references
196 Possible Orthologues:

Malt Paracaspase 1

Ensembl ID : ENSDARG00000077768
Gene Symbol: MALT1
10 Enzyme and pathways 5 Cross references
198 Possible Orthologues:

Mapk Activated Protein Kinase 2a

Ensembl ID : ENSDARG00000002552
Gene Symbol: MAPKAPK2A
50 Enzyme and pathways 5 Cross references
145 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).